Emergent BioSolutions (EBS) Receivables - Net (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Receivables - Net of $121.6 million for Q1 2026, down 40.3% year-over-year from $203.7 million in Q1 2025, and up 44.42% quarter-over-quarter from $84.2 million in Q4 2025.
Emergent BioSolutions (EBS) Receivables - Net (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Receivables - Net history runs 17 years deep, the most recent figure standing at $121.6 million for Q1 2026.
- In Q1 2026, Receivables - Net fell 40.3% year-over-year to $121.6 million; the TTM figure through Mar 2026 stood at $121.6 million (down 40.3% YoY), while the FY2025 annual figure was $84.2 million, down 45.5% from the prior year.
- Receivables - Net for Q1 2026 stood at $121.6 million, up from $84.2 million in the prior quarter.
- The five-year high for Receivables - Net was $290.1 million in Q2 2023, with the low at $79.8 million in Q2 2025.
- The 5-year median for Receivables - Net is $175.0 million (2022), against an average of $167.4 million.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net slumped 63.18% in 2022, then jumped 85.98% in 2023.
- Emergent BioSolutions' Receivables - Net stood at $102.7 million in 2022, then jumped by 85.98% to $191.0 million in 2023, then slipped by 19.11% to $154.5 million in 2024, then sank by 45.5% to $84.2 million in 2025, then soared by 44.42% to $121.6 million in 2026.
- Business Quant data shows EBS's Receivables - Net at $121.6 million in Q1 2026, $84.2 million in Q4 2025, and $149.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 190.00 Mn |
| Jun 30, 2026 | 190.00 Mn |
| Mar 31, 2026 | 121.60 Mn |
| Mar 31, 2026 | 121.60 Mn |
| Dec 31, 2025 | 84.20 Mn |
| Dec 31, 2025 | 84.20 Mn |
| Sep 30, 2025 | 149.50 Mn |
| Sep 30, 2025 | 149.50 Mn |
| Jun 30, 2025 | 79.80 Mn |
| Jun 30, 2025 | 79.80 Mn |
| Mar 31, 2025 | 203.70 Mn |
| Mar 31, 2025 | 203.70 Mn |
| Dec 31, 2024 | 154.50 Mn |
| Dec 31, 2024 | 154.50 Mn |
| Sep 30, 2024 | 121.30 Mn |
| Sep 30, 2024 | 121.30 Mn |
| Jun 30, 2024 | 196.30 Mn |
| Jun 30, 2024 | 196.30 Mn |
| Mar 31, 2024 | 233.50 Mn |
| Mar 31, 2024 | 233.50 Mn |